Formed in 2016, the Precision Medicine Alliance (PMA) builds collaborative clinical programs throughout CommonSpirit’s 21-state footprint, currently with focus areas including precision oncology and physician education.
In support of CommonSpirit Health’s mission, the PMA works with providers to integrate advanced genomic solutions into clinical practice as well as develop initiatives to build healthier communities.
The PMA aims to promote wellness throughout CommonSpirit Health by expanding community access to a portfolio of precision medicine offerings. These offerings will measurably improve outcomes and lower costs. This comprehensive, value-based solution will create access to precision medicine capabilities by:
Aiming to become a global leader in precision medicine content expertise and clinical practice as it revolutionizes the ways that care is delivered to consumers and populations in the communities we serve.
Embracing our academic and industry partners to design precision medicine programs for deployment across the personalized care ecosystem in areas such as oncology, cardiovascular disease, and rare diseases.
Becoming a learning organization that relentlessly strives to expand our knowledge and expertise in precision medicine and population health through collaborative relationships with patients, providers, researchers, and clinical institutes.
Tirelessly seeking ways to add value to CommonSpirit Health by utilizing precision medicine at the right place, at the right time, and for the right individual.
Expanding access to state-of-the-art precision medicine preventive, diagnostic, and treatment modalities to all we serve.
Utilizing the reach of CommonSpirit Health to address existing challenges in precision medicine, such as patient and provider adoption, payer engagement, translation of science to clinical practice, data harmonization, and regulatory issues.